After Dobbs: The Impact on Reproductive Medicine
- November 04, 2022
The field of reproductive medicine is beginning to feel the effects of the post-Dobbs landscape. Delphine O’Rourke, Partner, Goodwin Procter LLP, speaks with Dr. Brian Levine, Founding Partner and Practice Director, CCRM New York, about how the field is reacting, particularly as it relates to innovation, surrogacy, and access to treatment. Dr. Levine is a leader in the field of reproductive medicine and the founder of Nodal, a surrogacy platform that is driving transparency between surrogates and intended parents.
You must be logged in to access this content.